Breast implant-associated ALK-negative anaplastic large cell lymphoma: A case report and discussion of possible pathogenesis

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 8, 2013, Pages 1631-1642

  George, Eva V ^a   Pharm, John ^b   Houston, Courtney ^b   Al Quran, Semar ^a   Brian, Grey ^a   Dong, Huijia ^a   Hai, Wang ^a   Reeves, Westley ^a   Yang, Li Jun ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b John D Archbold Memorial Hospital   (United States)

Author keywords

Alk Negative; Anaplastic Large Cell Lymphoma (Alcl); Breast Implant; Ectopic Lymphoid Aggregates; Pathogenesis

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PROTEIN TYROSINE KINASE;

AGED; ALK-NEGATIVE; ANAPLASTIC LARGE CELL LYMPHOMA (ALCL); ARTICLE; BREAST IMPLANT; BREAST TUMOR; CASE REPORT; ECTOPIC LYMPHOID AGGREGATES; FEMALE; HUMAN; LARGE CELL LYMPHOMA; PAGET NIPPLE DISEASE; PATHOGENESIS; PATHOLOGY; SECOND CANCER;

ALK-NEGATIVE; ANAPLASTIC LARGE CELL LYMPHOMA (ALCL); BREAST IMPLANT; ECTOPIC LYMPHOID AGGREGATES; PATHOGENESIS;

AGED; BREAST IMPLANTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; NEOPLASMS, SECOND PRIMARY; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84882966180     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Brinton LA and Brown SL. Breast implants and cancer. J Natl Cancer Inst 1997; 89: 1341-1349.
2. de JD, Vasmel WL, de Boer JP, Verhave G, Barbe E, Casparie MK , van Leeuwen FE. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008; 300: 2030-2035.
3. Lazzeri D, Agostini T, Bocci G, Giannotti G, Fanelli G, Naccarato AG, Danesi R, Tuccori M, Pantaloni M , D'Aniello C. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer 2011; 11: 283-296.
4. Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings , Analyses. 2011.
5. Ferreri AJ, Govi S, Pileri SA , Savage KJ. Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol 2013; 85: 206-215.
6. Story SK, Schowalter MK , Geskin LJ. Breast Implant-Associated ALCL: A Unique Entity in the Spectrum of CD30+ Lymphoproliferative Disorders. Oncologist 2013; 18: 301-7.
7. Carty MJ, Pribaz JJ, Antin JH, Volpicelli ER, Toomey CE, Farkash EA , Hochberg EP. A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg 2011; 128: 112e-118e.
8. Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ, Jorgensen JL, de Peralta-Venturina M, Mustafa EB, Young KH, You MJ, Fayad LE, Blenc AM , Miranda RN. Anaplastic Large Cell Lymphoma Associated With Breast Implants: A Report of 13 Cases. Am J Surg Pathol 2012; 36: 1000-1008.
9. Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ, Jorgensen JL, de Peralta-Venturina M, Mustafa EB, Young KH, You MJ, Fayad LE, Blenc AM , Miranda RN. Anaplastic Large Cell Lymphoma Associated With Breast Implants: A Report of 13 Cases. Am J Surg Pathol 2012; 36: 1000-1008.
10. Newman MK, Zemmel NJ, Bandak AZ , Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: a case report , review of the literature. J Plast Reconstr Aesthet Surg 2008; 61: 822-825.
11. Taylor CR, Siddiqi IN , Brody GS. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic , immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol 2013; 21: 13-20.
12. Bishara MR, Ross C , Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol 2009; 4: 11.
13. de JD, Vasmel WL, de Boer JP, Verhave G, Barbe E, Casparie MK , van Leeuwen FE. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008; 300: 2030-2035.
14. Farkash EA, Ferry JA, Harris NL, Hochberg EP, Takvorian RW, Zuckerman DS , Sohani AR. Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls. J Hematop 2009; 2: 237-244.
15. Fritzsche FR, Pahl S, Petersen I, Burkhardt M, Dankof A, Dietel M , Kristiansen G. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer--a case report. Virchows Arch 2006; 449: 561-564.
16. Gaudet G, Friedberg JW, Weng A, Pinkus GS , Freedman AS. Breast lymphoma associated with breast implants: two case-reports , a review of the literature. Leuk Lymphoma 2002; 43: 115-119.
17. Joks M, Mysliwiec K , Lewandowski K. Primary breast lymphoma - a review of the literature , report of three cases. Arch Med Sci 2011; 7: 27-33.
18. Lechner MG, Lade S, Liebertz DJ, Prince HM, Brody GS, Webster HR , Epstein AL. Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment , characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer 2011; 117: 1478-1489.
19. Li S , Lee AK. Silicone implant , primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol 2009; 3: 117-127.
20. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA , Chadburn A Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report , review of the literature. Arch Pathol Lab Med 2003; 127: e115-e118.
21. Wong AK, Lopategui J, Clancy S, Kulber D , Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report , review of the literature. Am J Surg Pathol 2008; 32: 1265-1268.
22. Smith TJ , Ramsaroop R. Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion. Breast 2012; 21: 102-104.
23. Keech JA Jr , Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997; 100: 554-555.
24. Olack B, Gupta R , Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg 2007; 59: 56-57.
25. Popplewell L, Thomas SH, Huang Q, Chang KL , Forman SJ. Primary anaplastic large-cell lymphoma associated with breast implants. Leuk Lymphoma 2011; 52: 1481-1487.
26. Jewell M, Spear SL, Largent J, Oefelein MG , Adams WP Jr. Anaplastic large T-cell lymphoma , breast implants: a review of the literature. Plast Reconstr Surg 2011; 128: 651-661.
27. Largent J, Oefelein M, Kaplan HM, Okerson T , Boyle P. Risk of lymphoma in women with breast implants: analysis of clinical studies. Eur J Cancer Prev 2012; 21: 274-280.
28. Lechner MG, Lade S, Liebertz DJ, Prince HM, Brody GS, Webster HR , Epstein AL. Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment , characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer 2011; 117: 1478-1489.
29. Theodorou I, Delfau-Larue MH, Bigorgne C, Lahet C, Cochet G, Bagot M, Wechsler J , Farcet JP. Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction , denaturing gradient gel electrophoresis. Blood 1995; 86: 305-310.
30. Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG , Bhagat G. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 2009; 50: 831-833.
31. Muller PA , Vousden KH. p53 mutations in cancer. Nat Cell Biol 2013; 15: 2-8.
32. Wade M, Li YC , Wahl GM. MDM2, MDMX , p53 in oncogenesis , cancer therapy. Nat Rev Cancer 2012; 13: 83-96.
33. Thomasova D, Mulay SR, Bruns H , Anders HJ. p53-independent roles of MDM2 in NF-kappaB signaling: implications for cancer therapy, wound healing, , autoimmune diseases. Neoplasia 2012; 14: 1097-1101.
34. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki IM, Honjo T , Chiba T. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 2007; 13: 470-476.
35. Komori J, Marusawa H, Machimoto T, Endo Y, Kinoshita K, Kou T, Haga H, Ikai I, Uemoto S , Chiba T. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology 2008; 47: 888-896.
36. Okazaki I, Yoshikawa K, Kinoshita K, Muramatsu M, Nagaoka H , Honjo T. Activation-induced cytidine deaminase links class switch recombination , somatic hypermutation. Ann N Y Acad Sci 2003; 987: 1-8.
37. Harvey M, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A , Donehower LA. Spontaneous , carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993; 5: 225-229.
38. Rauch D, Gross S, Harding J, Niewiesk S, Lairmore M, Piwnica-Worms D , Ratner L. Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood 2009; 113: 1493-1500.
39. Finnberg N, Klein-Szanto AJ , El-Deiry WS. TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation , tumorigenesis. J Clin Invest 2008; 118: 111-123.
40. Drayton DL, Liao S, Mounzer RH , Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006; 7: 344-353.
41. Kratz A, Campos-Neto A, Hanson MS , Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996; 183: 1461-1472.
42. Kong J, Deng X, Wang Z, Yang J, Zhang Y , Yu J. Hepatitis C virus F protein: A double-edged sword in the potential contribution of chronic inflammation to carcinogenesis. Mol Med Rep 2009; 2: 461-469.
43. Park YW, Pryshchep S, Seyler TM, Goronzy JJ , Weyand CM. B cells as a therapeutic target in autoimmune diseases. Expert Opin Ther Targets 2005; 9: 431-445.
44. Lamant L, Pileri S, Sabattini E, Brugieres L, Jaffe ES , Delsol G. Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases. Haematologica 2010; 95: 449-455.
45. Reeves WH, Lee PY, Weinstein JS, Satoh M , Lu L. Induction of autoimmunity by pristane , other naturally occurring hydrocarbons. Trends Immunol 2009; 30: 455-464.
46. Potter M, Morrison S , Miller F. Induction of plasmacytomas in genetically susceptible mice with silicone gels. Curr Top Microbiol Immunol 1995; 194: 83-91.